期刊文献+

腹膜后局限型Castleman病2例报告及文献复习 被引量:3

A report of two cases of reroperitoneal local Castleman disease and analysis of the literature
下载PDF
导出
摘要 目的提高对腹膜后局限型Castleman病的认识和诊治水平。方法回顾性分析2例Castleman病患者的诊治过程并进行文献复习。结果 2例患者术前均未明确诊断,成功行手术切除,术后病理证实为Castleman病,在临床分类上均属于局限型。术后随访6-12个月,未见肿瘤复发。结论 Castleman病临床表现无特异性,可发生于淋巴组织的任何部位,术前CT检查对诊断该病有一定帮助,确诊有赖于病理学检查,手术切除为首选治疗方法 ,综合治疗可获得较佳疗效。 Objective To improve the abiliteies of abilities of awareness and diagnosis and treatment of retroperitoneal local Castleman disease.MethodsRetrospectively analyze the diagnosis and treatment information and clinical features of 2 retroperitoneal local Castleman disease patients from 2008 to 2009 in Luwan Banch of Ruijing Hospital of Shanghai Jiaotong University School of Medicine and review related literatures simultaneously.ResultsNo definite diagnosis was made for both 2 patients before operation,surgical resection of tumors were both successful.Pathological diagnosis were Castleman disease,both in the clinical classification were localized.We followed up for 6 to 12 months,no tumor recurrence.ConclusionsNo specific clinical manifestations of Castleman disease,could occur in any part of the lymphatic tissue,preoperative CT examination in the diagnosis of the disease have some help,diagnosis depended on pathological examination,surgical excision is the preferred treatment,get better effect of combined therapy.
出处 《现代泌尿生殖肿瘤杂志》 2011年第2期77-79,82,共4页 Journal of Contemporary Urologic and Reproductive Oncology
关键词 CASTLEMAN病 诊断 治疗 Catleman disease Diagnosis Treatment
  • 相关文献

参考文献19

  • 1Newlon JL,Couch M,Brennan J.Castleman's disease:three case reports and a review of the literature[J].Ear Nose Throat J,2007,86(7):414-418.
  • 2Bowne WB,Lewis JJ,Filippa DA,et al.The management of unicentric and multicentric Castleman's disease:a report of 16 cases and a review of the literature[J].Cancer,1999,85(3):706-717.
  • 3Chronowski GM,Ha CS,Wilder RB,et al.Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy[J].Cancer,2001,92(3):670-676.
  • 4Herrada J,Cabanillas F,Rice L,et al.The clinical 0 behavior of localized and multicentric Castleman disease[J].Ann Intern Med,1998,128(8):657-662.
  • 5Powles T,Stebbing J,Montoto S,et al.Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease[J].Blood,2007,110(12):4132-4133.
  • 6Dispenzieri A,Gertz MA.Treatment of Castleman's disease[J].Curr Treat Options Oncol,2005,6(3):255-266.
  • 7Baserga M,Rosin M,Schoen M,et al.Muhifocal Castleman disease in pediatrics:case report[J].J Pediatr Hematol Oncol,2005,27(12):666-669.
  • 8Kawabata H,Tomosugi N,Kanda J,et al.Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease[J].Haematologica,2007,92(6):857-858.
  • 9Zoeteweij JP,Eyes ST,Orenstein JM,et al.Identification and rapid quantification of early-and late-lytic human herpesvirus 8 infection in single cells by flow cytometric analysis:characterization of antiherpesvirus agents[J].J Virol,1999,73(7):5894-5902.
  • 10Parravcini C,Corbellino M,Paulli M,et al.Expression of a virus-derived cytokine,KSHV vIL-6,in HIV-seronegative Castleman's disease[J].Am J Pathol,1997,151(6):1517-1522.

二级参考文献14

  • 1Castleman B,Lverson L,Menendex V.Localized mediastinal lymph node hyerplasia resembling thymoma?[J].Cancer,1956,9:822-830.
  • 2Dupin N,Diss TL,Kellam P,et al.HHV-8 is associated with a plasmablastic variant of astleman disease that is linked to HHV-8 positive plasmablastic lymphoma[J].Blood,2000,95:1406-1412.
  • 3Mikala G,Xie J,Berencsi G,et al.Human herpe svirus 8 in hematologic diseases[J].Pathol Oncol Res,1999,5(1):73-79.
  • 4Iec L,Mohamed AS,Authier FJ,et al.Human herpesvirus 8 infection in patients with POEMS syndrome-associated multicentric Castleman's disease[J].Blood,1996,93(11):3643-3653.
  • 5Du MQ,Diss TC,Liu H,et al.KSHV-and EBV-associated germinotropic lymphoproliferative disorder[J].Blood,2002,100(9):415-418.
  • 6Du MQ,Liu H,Diss TC,et al.Kaposi sarcoassociated herpes virus infects monotypi c (IgM lambda) butpolyclonal naive B cells inCastleman disease and associated lymphoproliferative disorders[J].Blood,2001,97(7):2130-2136.
  • 7Norihiro N,Mitsuko S,Yoshihito S,et al.mpro-vement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy[J].Blood,2000,95(1):56-63.
  • 8Frizzera G.Castleman's disease and related disorders[J].Semin Diag Pathol,1988,5:346-364.
  • 9Dupin N,Diss T L,Kellam P,et al.HHV-8 is associated with aplasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablasticlymphoma[J].Blood,2000,95:1406-1412.
  • 10Bowne W B,Lewis J J,Filippa D A,et al.The management of unicentric and multicentric Castleman's disease:a report of 16 cases and a review of the literature[J].Cancer,1999,85:706-717.

共引文献13

同被引文献32

  • 1Kojima M,Nakamura N,Tsukamoto N,et al.Clinical implications of idiopathic multicentric Castleman disease among Japanese:a report of 28 cases[J].Int J Surg Pathol,2008,16(4):391-398.
  • 2Seliem RM,Griffith RC,Harris NL,et al.HHV-8+,EBV+ multicentric plasmablastic microlymphoma in an HIV+ Man:the spectrum of HHV-8+ lymphoproliferative disorders expands[J].Am J Surg Pathol,2007,31(9):1439-1445.
  • 3Bower M,Powles T,Williams S,et al.Brief communication:rituximab in HIV-associated multicentric Castleman disease[J].Ann Intern Med,2007,147(12):836-839.
  • 4Matsuyama M,Suzuki T,Tsuboi H,et al.Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease[J].Intern Med,2007,46(11):771-774.
  • 5Castleman B,Towne VW.Case records of the Massachusetts General Hospital:Case No.40231[J].N Engl J Med,1954,250(23):1001-1005.
  • 6Frizzera G.Castleman's disease and related disorders[J].Semin Diagn Pathol,1988,5(4):346-364.
  • 7Casper C.The aetiology and management of Castleman disease at 50 years:translating pathophysiology to patient care[J].Br J Haematol,2005,129(1):3-17.
  • 8Dham A,Peterson B.Castleman disease[J].Curr Opin Hematol,2007,14(4):354-359.
  • 9Coca S,Salas I,Martínez R,et al.Meningeal Castleman's disease with multifocal involvement:a case report and review of literature[J].J Neurooncol,2008,88(1):37-41.
  • 10Powles T, Stebbing J, Montoto S, et al. Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease[J]. Blood, 2007, 110.. 4132-4133.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部